Page last updated: 2024-09-04

(e)-3-(4-t-butylphenyl)-n-(2,3-dihydrobenzo(b)(1,4)dioxin-6-yl)acrylamide and kallidin

(e)-3-(4-t-butylphenyl)-n-(2,3-dihydrobenzo(b)(1,4)dioxin-6-yl)acrylamide has been researched along with kallidin in 1 studies

Compound Research Comparison

Studies
((e)-3-(4-t-butylphenyl)-n-(2,3-dihydrobenzo(b)(1,4)dioxin-6-yl)acrylamide)
Trials
((e)-3-(4-t-butylphenyl)-n-(2,3-dihydrobenzo(b)(1,4)dioxin-6-yl)acrylamide)
Recent Studies (post-2010)
((e)-3-(4-t-butylphenyl)-n-(2,3-dihydrobenzo(b)(1,4)dioxin-6-yl)acrylamide)
Studies
(kallidin)
Trials
(kallidin)
Recent Studies (post-2010) (kallidin)
850655341224

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Allcock, BK; Gerovac, TA; McChesney, SL; Miranpuri, GS; Park, SW; Rajpal, S; Resnick, DK; Tilghman, JI; Turner, NA1

Other Studies

1 other study(ies) available for (e)-3-(4-t-butylphenyl)-n-(2,3-dihydrobenzo(b)(1,4)dioxin-6-yl)acrylamide and kallidin

ArticleYear
Antihyperalgesic effects of vanilloid-1 and bradykinin-1 receptor antagonists following spinal cord injury in rats.
    Journal of neurosurgery. Spine, 2007, Volume: 6, Issue:5

    Topics: Acrylamides; Animals; Bradykinin Receptor Antagonists; Bridged Bicyclo Compounds, Heterocyclic; Hyperalgesia; Kallidin; Male; Rats; Rats, Sprague-Dawley; Spinal Cord Injuries; TRPV Cation Channels

2007